Complex Generics: US FDA, Sponsors View Roadblocks Very Differently

 
• By Derrick Gingery
The US FDA approval process for complex generic drugs continues to vex sponsors, who want a more predictable timeline. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics